These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28099577)

  • 21. Human β-defensin 2 and protease activated receptor-2 expression in patients with chronic periodontitis.
    Pereira AL; Holzhausen M; Franco GC; Cortelli SC; Cortelli JR
    Arch Oral Biol; 2012 Dec; 57(12):1609-14. PubMed ID: 22647427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of nonsurgical periodontal therapy with oral hygiene instruction alone for chronic periodontitis.
    Asad M; Abdul Aziz AW; Raman RP; Harun HW; Ali TB; Chinna K; Vaithilingam RD
    J Oral Sci; 2017; 59(1):111-120. PubMed ID: 28367891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trefoil factors in saliva and gingival tissues of patients with chronic periodontitis.
    Chaiyarit P; Chayasadom A; Wara-Aswapati N; Hormdee D; Sittisomwong S; Nakaresisoon S; Samson MH; Pitiphat W; Giraud AS
    J Periodontol; 2012 Sep; 83(9):1129-38. PubMed ID: 22181686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short term effects of non-surgical periodontal treatment on gingival crevicular fluid levels of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 2 (PAI-2) in patients with chronic and aggressive periodontitis.
    Tüter G; Ozdemir B; Kurtiş B; Serdar M; Yücel AA; Ayhan E
    Arch Oral Biol; 2013 Apr; 58(4):391-6. PubMed ID: 22980426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treponema denticola associates with increased levels of MMP-8 and MMP-9 in gingival crevicular fluid.
    Yakob M; Meurman JH; Sorsa T; Söder B
    Oral Dis; 2013 Oct; 19(7):694-701. PubMed ID: 23294114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of initial periodontal therapy on oxidative stress markers in gingival crevicular fluid, saliva, and serum in smokers and non-smokers with chronic periodontitis.
    Hendek MK; Erdemir EO; Kisa U; Ozcan G
    J Periodontol; 2015 Feb; 86(2):273-82. PubMed ID: 25325515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).
    Seror R; Theander E; Brun JG; Ramos-Casals M; Valim V; Dörner T; Bootsma H; Tzioufas A; Solans-Laqué R; Mandl T; Gottenberg JE; Hachulla E; Sivils KL; Ng WF; Fauchais AL; Bombardieri S; Valesini G; Bartoloni E; Saraux A; Tomsic M; Sumida T; Nishiyama S; Caporali R; Kruize AA; Vollenweider C; Ravaud P; Vitali C; Mariette X; Bowman SJ;
    Ann Rheum Dis; 2015 May; 74(5):859-66. PubMed ID: 24442883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Periodontal status and serum antibody responses to oral microorganisms in Sjögren's syndrome.
    Celenligil H; Eratalay K; Kansu E; Ebersole JL
    J Periodontol; 1998 May; 69(5):571-7. PubMed ID: 9623900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of azithromycin, as an adjunct to nonsurgical periodontal treatment, on microbiological parameters and gingival crevicular fluid biomarkers in generalized aggressive periodontitis.
    Emingil G; Han B; Ozdemir G; Tervahartiala T; Vural C; Atilla G; Baylas H; Sorsa T
    J Periodontal Res; 2012 Dec; 47(6):729-39. PubMed ID: 22571226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutritional intervention in patients with periodontal disease: clinical, immunological and microbiological variables during 12 months.
    Jenzsch A; Eick S; Rassoul F; Purschwitz R; Jentsch H
    Br J Nutr; 2009 Mar; 101(6):879-85. PubMed ID: 18713481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-33 levels in gingival crevicular fluid, saliva, or plasma do not differentiate chronic periodontitis.
    Buduneli N; Özçaka Ö; Nalbantsoy A
    J Periodontol; 2012 Mar; 83(3):362-8. PubMed ID: 21859321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salivary interleukin-1β levels in patients with chronic periodontitis before and after periodontal phase I therapy and healthy controls: a case-control study.
    Kaushik R; Yeltiwar RK; Pushpanshu K
    J Periodontol; 2011 Sep; 82(9):1353-9. PubMed ID: 21235331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and microbiological efficacy of systemic roxithromycin as an adjunct to non-surgical periodontal therapy in treatment of chronic periodontitis. A randomized, double-blinded, placebo-controlled clinical trial.
    Martande SS; Pradeep AR; Kumari M; Priyanka N; Singh SP; Naik SB; Patel SP; Bagchi P
    Am J Dent; 2015 Jun; 28(3):137-42. PubMed ID: 26201224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minor gland saliva flow rate and proteins in subjects with hyposalivation due to Sjogren's syndrome and radiation therapy.
    Eliasson L; Almståhl A; Lingström P; Wikström M; Carlén A
    Arch Oral Biol; 2005 Mar; 50(3):293-9. PubMed ID: 15740707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chronic periodontitis on serum and gingival crevicular fluid oxidant and antioxidant status in patients with familial Mediterranean fever before and after periodontal treatment.
    Bostanci V; Toker H; Senel S; Ozdemir H; Aydin H
    J Periodontol; 2014 May; 85(5):706-12. PubMed ID: 23826647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjögren's syndrome.
    Kabeerdoss J; Sandhya P; Mandal SK; Gowri M; Danda D
    Clin Rheumatol; 2016 Dec; 35(12):3063-3067. PubMed ID: 27620619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Full-mouth ultrasonic debridement associated with amoxicillin and metronidazole in the treatment of severe chronic periodontitis.
    Ribeiro Edel P; Bittencourt S; Zanin IC; Bovi Ambrosano GM; Sallum EA; Nociti FH; Gonçalves RB; Casati MZ
    J Periodontol; 2009 Aug; 80(8):1254-64. PubMed ID: 19656025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid peroxidation levels, total oxidant status and superoxide dismutase in serum, saliva and gingival crevicular fluid in chronic periodontitis patients before and after periodontal therapy.
    Wei D; Zhang XL; Wang YZ; Yang CX; Chen G
    Aust Dent J; 2010 Mar; 55(1):70-8. PubMed ID: 20415915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gingival crevicular fluid interleukin-36β (-1F8), interleukin-36γ (-1F9) and interleukin-33 (-1F11) levels in different periodontal disease.
    Kurşunlu SF; Oztürk VÖ; Han B; Atmaca H; Emingil G
    Arch Oral Biol; 2015 Jan; 60(1):77-83. PubMed ID: 25247780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study).
    Meiners PM; Vissink A; Kroese FG; Spijkervet FK; Smitt-Kamminga NS; Abdulahad WH; Bulthuis-Kuiper J; Brouwer E; Arends S; Bootsma H
    Ann Rheum Dis; 2014 Jul; 73(7):1393-6. PubMed ID: 24473674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.